BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nyström K, Waldenström J, Tang K, Lagging M. Ribavirin: pharmacology, multiple modes of action and possible future perspectives. Future Virology 2019;14:153-60. [DOI: 10.2217/fvl-2018-0166] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Goswami D. Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow. RSC Adv 2021;11:29015-28. [DOI: 10.1039/d1ra04460e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Punekar M, Kshirsagar M, Tellapragada C, Patil K. Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system. Microb Pathog 2022;168:105608. [PMID: 35654381 DOI: 10.1016/j.micpath.2022.105608] [Reference Citation Analysis]
3 Mero HR, Lyantagaye SL, Bongcam-Rudloff E. Why has permanent control of cassava brown streak disease in Sub-Saharan Africa remained a dream since the 1930s? Infect Genet Evol 2021;94:105001. [PMID: 34271188 DOI: 10.1016/j.meegid.2021.105001] [Reference Citation Analysis]
4 Couroux P, Brkovic A, Vittitow JL, Israel RJ, Pamidi C, Patel J, Barakat M. A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin. Clin Transl Sci 2022. [PMID: 35677972 DOI: 10.1111/cts.13350] [Reference Citation Analysis]
5 Vicenti I, Martina MG, Boccuto A, De Angelis M, Giavarini G, Dragoni F, Marchi S, Trombetta CM, Crespan E, Maga G, Eydoux C, Decroly E, Montomoli E, Nencioni L, Zazzi M, Radi M. System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. Eur J Med Chem 2021;224:113683. [PMID: 34273661 DOI: 10.1016/j.ejmech.2021.113683] [Reference Citation Analysis]
6 Tarighi P, Eftekhari S, Chizari M, Sabernavaei M, Jafari D, Mirzabeigi P. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur J Pharmacol 2021;895:173890. [PMID: 33482181 DOI: 10.1016/j.ejphar.2021.173890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
7 Luo W, Ige OO, Beacon TH, Su RC, Huang S, Davie JR, Lakowski TM. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression. Genome 2021;64:400-15. [PMID: 33197212 DOI: 10.1139/gen-2020-0130] [Reference Citation Analysis]
8 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
9 Talemi SR, Bartenschlager M, Schmid B, Ruggieri A, Bartenschlager R, Höfer T. Dengue virus is sensitive to inhibition prior to productive replication. Cell Rep 2021;37:109801. [PMID: 34644578 DOI: 10.1016/j.celrep.2021.109801] [Reference Citation Analysis]
10 Unal MA, Bitirim CV, Summak GY, Bereketoglu S, Cevher Zeytin I, Besbinar O, Gurcan C, Aydos D, Goksoy E, Kocakaya E, Eran Z, Murat M, Demir N, Aksoy Ozer ZB, Somers J, Demir E, Nazir H, Ozkan SA, Ozkul A, Azap A, Yilmazer A, Akcali KC. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro. Can J Physiol Pharmacol 2021;99:449-60. [PMID: 33689451 DOI: 10.1139/cjpp-2020-0734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sabat N, Ouarti A, Migianu-griffoni E, Lecouvey M, Ferraris O, Gallier F, Peyrefitte C, Lubin-germain N, Uziel J. Synthesis, antiviral and antitumor activities investigations of a series of Ribavirin C-nucleoside analogue prodrugs. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105723] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tian L, Qiang T, Liang C, Ren X, Jia M, Zhang J, Li J, Wan M, YuWen X, Li H, Cao W, Liu H. RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. Eur J Med Chem 2021;213:113201. [PMID: 33524687 DOI: 10.1016/j.ejmech.2021.113201] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]